2021
DOI: 10.1002/cnr2.1413
|View full text |Cite
|
Sign up to set email alerts
|

Clinical outcomes in cancer patients with COVID‐19

Abstract: Background Early reports on cancer patients with coronavirus disease 2019 (COVID‐19) corroborated speculation that cancer patients are at increased risk for becoming infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and developing severe COVID‐19. However, cancer patients are a heterogeneous population and their corresponding risk may be different. Aim To compare COVID‐19 presentation in patients with active malignancy to those with a history of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 31 publications
1
9
0
Order By: Relevance
“…However, infection- and all-cause mortality was higher in patients with active cancer and exceeded mortality in patients with non-active cancer by 1.5- to 1.7-fold. Similar findings have been reported elsewhere [11, 15, 18, 19]. Of 580 cancer patients, positively tested for SARS-CoV-2 at New York University Langone Hospital, for example, 221 had active cancer.…”
Section: Discussionsupporting
confidence: 87%
“…However, infection- and all-cause mortality was higher in patients with active cancer and exceeded mortality in patients with non-active cancer by 1.5- to 1.7-fold. Similar findings have been reported elsewhere [11, 15, 18, 19]. Of 580 cancer patients, positively tested for SARS-CoV-2 at New York University Langone Hospital, for example, 221 had active cancer.…”
Section: Discussionsupporting
confidence: 87%
“…A study of nearly 7000 patients hospitalized in New York between 16 March and 31 July 2020 found active cancer was not associated with an increased risk of ICU admission but was associated with a higher risk of all‐cause mortality. Survival was more strongly associated with patients with a history of cancer as opposed to active cancer 5 . Another study of over 4000 hospitalized patients in New York echoed these findings 6 .…”
Section: Treatmentmentioning
confidence: 89%
“…Survival was more strongly associated with patients with a history of cancer as opposed to active cancer. 5 Another study of over 4000 hospitalized patients in New York echoed these findings. 6 A British study examined active cancer alongside other comorbidities, including diabetes mellitus, hypertension, coronary artery disease, and dyslipidemia, finding a death rate in active cancer patients to be nearly double.…”
Section: Treatmentmentioning
confidence: 90%
“…However, other data have indicated that patients hospitalized with coronavirus disease 2019 (COVID‐19) with or without cancer have similar outcomes when matched by age and number of comorbidities. The relationship between cancer status and survival outcome was assessed in hospitalized patients at NYU Langone Health who tested positive for COVID-19 during the height of the pandemic in New York [ 1 ]. A total of 6274 hospitalized patients were included, of whom 580 had either active cancer (n = 221; defined as treatment within 6 months of COVID-19 diagnosis or measurable disease at time of hospitalization) or a history of cancer (n = 359).…”
Section: How Covid-19 Impacted On Our Daily Practice Both Clinical An...mentioning
confidence: 99%